Vaccine trial Archives

Bharat Biotech starts phase III trials for Covaxin; will it be world’s cheapest vaccine?

0 Comments

COVID 19 News, FightagainstCoronaCovid 19, Covid Vaccine, fightagainstcorona, Vaccine trial

Bharat Biotech starts phase III trials for Covaxin; will it be world’s cheapest vaccine?

Bharat Biotech on Monday announced the commencement of phase III trials of the COVID-19 vaccine, Covaxin. It is the largest clinical trial conducted for a COVID-19 vaccine in India. The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR. This is India’s first phase 3 efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted in India. The trial has been registered with ICMR and approved by the Drugs Controller General of India. …

Bharat Biotech’s ‘Covaxin’ to be tested for Phase-3 trials in Uttar Pradesh

In a good news for millions of Indians, the coronavirus COVID-19 vaccine ‘Covaxin’ will be tested for its phase-3 trials in Uttar Pradesh’s Lucknow and Gorakhpur. It is to be noted that Bharat Biotech Ltd is developing this vaccine in collaboration with the Indian Council of Medical Research (ICMR). Uttar Praadesh's Additional Chief Secretary (Medical and Health) Amit Mohan Prasad on Wednesday (September 23) conveyed the state government's decision to test the anti-COVID-19 vaccine in Lucknow and Gorakhpur through a letter to Bharat Biotech International Limited’s director…

Astra Zeneca resumes Covid_19 vaccine trial after all-clear from British Regulators

Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill. "Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so," the company said in a statement. AstraZeneca announced on Wednesday it had "voluntarily paused" its trial of the vaccine developed alongside Oxford University after the volunteer developed…